Results 21 to 30 of about 516,933 (343)

Histiocytic sarcoma [PDF]

open access: yesRevista Brasileira de Hematologia e Hemoterapia, 2010
A 59-year-old white woman, SC, after being treated for pneumonia, presented with an increase in the size of lymph nodes. The immunohistochemical examination diagnosed histiocytic sarcoma. Relapse occurred 12 months after starting chemotherapy. The patient evolved with febrile neutropenia, septic shock and death.
Machado, Eduardo Silva   +4 more
openaire   +5 more sources

Sarcoma treatment in the era of molecular medicine

open access: yesEMBO Molecular Medicine, 2020
Sarcomas are heterogeneous and clinically challenging soft tissue and bone cancers. Although constituting only 1% of all human malignancies, sarcomas represent the second most common type of solid tumors in children and adolescents and comprise an ...
T. Grünewald   +41 more
semanticscholar   +1 more source

Myeloid sarcoma.

open access: yesCurrent opinion in hematology, 2020
PURPOSE OF REVIEW Myeloid sarcoma; also known as granulocytic sarcoma and chloroma, often occurs concomitantly with AML, and rarely without bone marrow involvement.
Omar A. Shahin, F. Ravandi
semanticscholar   +1 more source

A Validated Prognostic Biomarker Score for Adult Patients with Nonmetastatic Soft Tissue Sarcomas of the Trunk and Extremities

open access: yesTranslational Oncology, 2017
BACKGROUND: The prognostic value of serum biomarkers in soft tissue sarcoma (STS) is limited, and its clinical applicability is compromised by a common inability to adjust for important confounders.
Katja Maretty-Kongstad   +3 more
doaj   +1 more source

The Epidemiology of Sarcoma [PDF]

open access: yesClinical Sarcoma Research, 2012
AbstractSarcomas account for over 20% of all pediatric solid malignant cancers and less than 1% of all adult solid malignant cancers. The vast majority of diagnosed sarcomas will be soft tissue sarcomas, while malignant bone tumors make up just over 10% of sarcomas. The risks for sarcoma are not well-understood.
Zachary Burningham   +3 more
openaire   +4 more sources

Wnt inhibitory factor 1 (WIF1) methylation and its association with clinical prognosis in patients with chondrosarcoma

open access: yesScientific Reports, 2017
Chondrosarcoma (CS) is a rare cancer, but it is the second most common primary malignant bone tumor and highly resistant to conventional chemotherapy and radiotherapy.
Pei Liu   +4 more
doaj   +1 more source

Intrapelvic melanocytic schwannoma resection with computer-assisted navigation

open access: yesRadiology Case Reports, 2020
Melanocytic schwannoma is a rare nerve tumor characterized by melanin-producing neoplastic Schwann cells. Wide surgical resection is the management of choice for this tumor; however, anatomical location and proximity to nerve roots can make locating this
Caroline A. Gerhardt, BS   +4 more
doaj   +1 more source

Ewing Sarcoma

open access: yesSarcomas, 2019
Ewing sarcoma is a cancerous tumor that occurs in bones or soft tissues, such as cartilage or nerves. There are several types of Ewing sarcoma, including Ewing sarcoma of bone, extraosseous Ewing sarcoma, peripheral primitive neuroectodermal tumor (pPNET)
W. Alperstein, M. Trucco
semanticscholar   +1 more source

GSK3-beta as a candidate therapeutic target in soft tissue sarcomas

open access: yesJournal of Hematology & Oncology, 2021
Soft tissue sarcoma (STS) is a predominantly fatal rare malignancy with inadequate treatment options. Glycogen synthase kinase 3β (GSK-3β) is an emerging target in human malignancies. Its therapeutic relevance in STS is unknown.
S. Verbeke   +7 more
doaj   +1 more source

Histiocytic Sarcoma

open access: yesDefinitions, 2020
Histiocytic sarcoma, a rare malignant neoplasm showing morphologic and immunophenotypic features of histiocytes, is characterized typically by extranodal presentation and a dismal clinical course, particularly in patients with disseminated disease.
Xiaohua Qian
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy